No effect of combined coenzyme Q10 and selenium supplementation on atorvastatin-induced myopathy

References

• Thompson PD, Clarkson P, Karas RH. Statin-associated myopathy. JAMA. 2003;289:1681–90.
   PubMed Web of Science ®Google Scholar
• Bruckert E, Hayem G, Dejager S, Yau C, Begaud B. Mild to moderate muscular symptoms with high-dosage statin therapy in hyperlipidemic patients - the PRIMO study. Cardiovasc Drugs Ther. 2005;19:403–14.
   PubMed Web of Science ®Google Scholar
• Chatzizisis YS, Koskinas KC, Misirli G, Vaklavas C, Hatzitolios A, Giannoglou GD. Risk factors and drug interactions predisposing to statin-induced myopathy: implications for risk assessment, prevention and treatment. Drug Saf. 2010;33:171–87.
   PubMed Web of Science ®Google Scholar
• Laaksonen R. On the mechanisms of statin-induced myopathy. Clin Pharmacol Ther. 2006;79:529–31.
   PubMed Web of Science ®Google Scholar
• Joy TR, Hegele RA. Narrative review: statin-related myopathy. Ann Intern Med. 2009;150:858–68.
   PubMed Web of Science ®Google Scholar
• Quinzii CM, DiMauro S, Hirano M. Human coenzyme Q10 deficiency. Neurochem Res. 2007;32:723–7.
   PubMed Web of Science ®Google Scholar
• Mancuso M, Orsucci D, Volpi L, Calsolaro V, Siciliano G. Coenzyme Q10 in neuromuscular and neurodegenerative disorders. Curr Drug Targets. 2010;11:111–21.
   PubMed Web of Science ®Google Scholar
• Kumar A, Kaur H, Devi P, Mohan V. Role of coenzyme Q10 (CoQ10) in cardiac disease, hypertension and Meniere-like syndrome. Pharmacol Ther. 2009;124:259–68.
   PubMed Web of Science ®Google Scholar
• Mortensen SA, Leth A, Agner E, Rohde M. Dose-related decrease of serum coenzyme Q10 during treatment with HMG-CoA reductase inhibitors. Mol Aspects Med. 1997;18:S137–44.
   PubMed Web of Science ®Google Scholar
• Bargossi AM, Grossi G, Fiorella PL, Gaddi A, Di GR, Battino M. Exogenous CoQ10 supplementation prevents plasma ubiquinone reduction induced by HMG-CoA reductase inhibitors. Mol Aspects Med. 1994;15:S187–93.
   Web of Science ®Google Scholar
• Mabuchi H, Nohara A, Kobayashi J, Kawashiri MA, Katsuda S, Inazu A, Koizumi J; Hokuriku Lipid Research Group. Effects of CoQ10 supplementation on plasma lipoprotein lipid, CoQ10 and liver and muscle enzyme levels in hypercholesterolemic patients treated with atorvastatin: a randomized double-blind study. Atherosclerosis. 2007;195: 182–9.
   PubMed Web of Science ®Google Scholar
• Young JM, Florkowski CM, Molyneux SL, McEwan RG, Frampton CM, George PM, Scott RS. Effect of coenzyme Q(10) supplementation on simvastatin-induced myalgia. Am J Cardiol. 2007;100:1400–3.
   PubMed Web of Science ®Google Scholar
• Caso G, Kelly P, McNurlan MA, Lawson WE. Effect of coenzyme q10 on myopathic symptoms in patients treated with statins. Am J Cardiol. 2007;99:1409–12.
   PubMed Web of Science ®Google Scholar
• Bookstaver DA, Burkhalter NA, Hatzigeorgiou C. Effect of Coenzyme Q10 Supplementation on Statin-Induced Myalgias.Am J Cardiol. 2012;110:526–9.
   PubMed Web of Science ®Google Scholar
• Moosmann B, Behl C. Selenoprotein synthesis and side- effects of statins. Lancet. 2004;363:892–4.
   PubMed Web of Science ®Google Scholar
• Golomb BA, Kane T, Dimsdale JE. Severe irritability associated with statin cholesterol-lowering drugs. QJM. 2004;97: 229–35.
   PubMed Web of Science ®Google Scholar
• Brähler E, Scheer J. 1983. Der Giessener Beschwerdebogen (GBB). Bern: Huber.
   Google Scholar
• Vassend O, Lian L, Andersen HT. [Norwegian version of NEOPersonality Inventory, Symptom Checklist 90 Revised, and Giessen Subjective Complaints List]. Tidsskr NorPsykologforen. 1992;29:1150–60.
   Google Scholar
• Malt UF, Nerdrum P, Oppedal B, Gundersen R, Holte M, Lone J. Physical and mental problems attributed to dental amalgam fillings: a descriptive study of 99 self-referred patients compared with 272 controls. Psychosom Med. 1997;59:32–41.
   PubMed Web of Science ®Google Scholar
• Buss AH, Perry M. The aggression questionnaire. J Pers Soc Psychol. 1992;63:452–9.
   PubMed Web of Science ®Google Scholar
• Nashef L, Lane RJM. Screening for mitochondrial cytopathies: the sub-anaerobic threshold exercise test (SATET). J Neurol Neurosurg Psychiatry. 1989;52:1090–4.
   PubMed Web of Science ®Google Scholar
• Todd KH, Funk KG, Funk JP, Bonacci R. Clinical significance of reported changes in pain severity. Ann Emerg Med. 1996;27:485–9.
   PubMed Web of Science ®Google Scholar
• Todd KH. Clinical versus statistical significance in the assessment of pain relief. Ann Emerg Med. 1996;27:439–41.
   PubMed Web of Science ®Google Scholar
• Laaksonen R, Riihimaki A, Laitila J, Martensson K, Tikkanen MJ, Himberg JJ. Serum and muscle tissue ubiquinone levels in healthy subjects. J Lab Clin Med. 1995;125:517–21.
   PubMed Web of Science ®Google Scholar
• Laaksonen R, Jokelainen K, Sahi T, Tikkanen MJ, Himberg JJ. Decreases in serum ubiquinone concentrations do not result in reduced levels in muscle tissue during short-term simvastatin treatment in humans. Clin Pharmacol Ther. 1995;57:62–6.
   PubMed Web of Science ®Google Scholar
• Mohaupt MG, Karas RH, Babiychuk EB, Sanchez-Freire V, Monastyrskaya K, Iyer L, . Association between statin-associated myopathy and skeletal muscle damage. CMAJ. 2009;181:11–8.
   PubMed Web of Science ®Google Scholar